Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Clinical trial NCT03027674 · COMPLETED

Trial details

NCT number: NCT03027674
Sponsor: Pontificia Universidad Catolica de Chile
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Raynaud Phenomenon Due to Trauma Raynaud Disease System; Sclerosis Lupus Erythematosus, Systemic Dermatomyositis Ultrasound Therapy; Complications

Start date: 2016-08-01
Primary completion: 2016-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.